2633.HK
Strong BuyUnloved QualityJacobson Pharma Corporation Limited · Healthcare · Hong Kong · $242M
HKD 0.96 +0.0% · close 5 Oct · scored 3 Oct
Unloved Quality: Strong and cheap; the market has not turned yet.
Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
ABOUT JACOBSON PHARMA CORPORATION LIMITED
Read
Jacobson Pharma Corporation Limited, through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally. It operates in two segments, Generic Drugs and Branded Healthcare.
FINANCIAL SUMMARY (HKD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.6B | 1.3B | 1.5B | 1.6B | -0.4% | 1.6B | 1.6B | 1.7B | 2.3% |
| EPS (HKD) | 0.09 | 0.13 | 0.14 | 0.15 | 17.8% | 0.15 | 0.15 | 0.17 | 3.2% |
| Shares | 1.9B | 1.9B | 2.0B | 2.0B | +4.1% | 2.0B | — | — | — |
| Debt | 1.4B | 1.6B | 749.4M | 773.2M | -18.1% | 910.9M | — | — | — |
| Equity | 2.5B | 2.7B | 2.4B | 2.5B | -0.5% | — | — | — | — |
| Op CF | 406.9M | 630.1M | 484.4M | 526.8M | 9.0% | 328.4M | — | — | — |
| Inv CF | -49.9M | -135.0M | 43.3M | -297.8M | — | — | — | — | — |
| Fin CF | -357.9M | -36.6M | -1.1B | -131.3M | — | — | — | — | — |
Calmer than 89% of stocks we rank over the past year (21% a year).
How this is worked out
What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 2633.HK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 2633.HK | Jacobson Pharma Corporation Limited(you) | $242M | 92 | Strong Buy |
| 3839.HK | CPBIO Holding Company Limited | $249M | 94 | Strong Buy |
| 2161.HK | JBM (Healthcare) Limited | $172M | 89 | Strong Buy |
| 2348.HK | Dawnrays Pharmaceutical (Holdings) Limited | $188M | 99 | Strong Buy |
| 8049.HK | Jilin Province Huinan Changlong Bio-pharmacy Company Limited | $169M | 100 | Strong Buy |
| 3613.HK | Beijing Tong Ren Tang Chinese Medicine Company Limited | $582M | 93 | Strong Buy |
| 0239.HK | Pak Fah Yeow International Limited | $98M | 100 | Strong Buy |
| 0950.HK | Lee's Pharmaceutical Holdings Limited | $91M | 84 | Strong Buy |
| 2005.HK | SSY Group Limited | $1.0B | 88 | Strong Buy |
| 0570.HK | China Traditional Chinese Medicine Holdings Co. Limited | $806M | 61 | Hold |
Peer medians: ROE 5.7% · P/E 10.5x · Gross margin 42.9%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.